{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-24-000851","form_type":"8-K","ticker":"IGC","cik":"0001326205","company_name":"IGC Pharma, Inc.","filed_at":"2024-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.611841+00:00","generated_at":"2026-05-31T07:21:19.745047+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"IGC Pharma stockholders re-elect two directors, ratify auditor, approve 5M share grant","bullets":["Richard Prins (26,116,740 for) and Terry Lierman (27,800,503 for) re-elected as Class B directors until 2027.","Ratified Manohar Chowdhry & Associates as independent registered public accounting firm for 2025 fiscal year (42,587,128 for).","Approved grant of up to 5,000,000 common shares to employees, advisors, directors, and consultants.","Non-binding advisory vote indicates executive compensation votes will be held every three years.","Approximately 56.6% of outstanding shares (42,811,367) voted; 14,877,728 broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-24-000851","json":"https://secwatch.observer/filing/0001185185-24-000851.json","markdown":"https://secwatch.observer/filing/0001185185-24-000851.md","text":"https://secwatch.observer/filing/0001185185-24-000851.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326205/000118518524000851/0001185185-24-000851-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326205/000118518524000851/igc20240826_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:21:19.745047+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}